HempNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Extends Role of “Father of Marijuana Research” Raphael Mechoulam

In a news release issued early Tuesday, ABcann Global Corporation (TSXV: ABCN) announced that Raphael Mechoulam has agreed to extend his role as an advisor to the company. Aaron Keay, CEO and director of ABcann, spoke to the importance of this agreement in the news release. “Professor Mechoulam’s experience in medicinal cannabis is an invaluable resource for ABcann as we enter the most aggressive growth stage in the company’s history,” he stated. “The Company has invested heavily to build and extend its early leadership in advanced pharmaceutical-grade cannabis production. Professor Mechoulam’s advice, guidance, and unmatched expertise in the field has played a major role in achieving this.” Mechoulam is an Israeli organic chemist who is commonly regarded as the “Father of Marijuana Research.” Working in the field for more than five decades, some of his most noteworthy research accomplishments include determining the chemical structure of cannabidiol (CBD) in 1963, isolating and synthesizing tetrahydrocannabinol (THC) in 1964 and elucidating the structure of the brain’s first endogenous cannabinoid in 1992.

To view the full press release, visit http://nnw.fm/5ScTg

To learn more about ABcann Global Corporation, visit http://nnw.fm/M6Ibv

About ABcann Global Corporation

ABcann Global Corporation is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. Its flagship operation, ABcann Medicinals Inc., was one of the first companies to obtain a production license under Canada’s Marihuana for Medical Purposes Regulations, which were enacted in July 2013. Since 2014, the company has focused on changing the face of medical cannabis. Today, every variable in its growing, curing and harvesting process is controlled and monitored by computer. This indoor, high-tech growing environment has resulted in a superior product that’s clean, consistent and repeatable; qualities that physicians and patients are looking for. For more information, visit the company’s website at www.ABcannGlobal.com

About NetworkNewsBreak

NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of HempWire (HW). NNB keeps you up-to-date on active US Public Companies complementary to HW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

Please see full disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, CO
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net